Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

Amgen profits down on rising costs

R&D and general operating expenses cancel out rise in product sales

- PMLiVE

Roche’s Avastin gains new US colon cancer approval

Patients can continue to use drug once disease progresses

- PMLiVE

Teva suffers setback as Nuvigil fails late-stage trial

Disappointing results in treating bipolar disorder but drug development continues

Novartis building

Novartis expects tough 2013 before a return to growth

Says it will take a year for new medicine sales to overcome Diovan patent loss

- PMLiVE

Bayer’s Jörg Reinhardt to replace Daniel Vasella as Novartis chair

Vasella leaves after 17 years at Swiss pharma company

Dodge promotes Chowning Johnson Aguilera to vice president

Healthcare industry veteran to provide strategic oversight for US comms agency

Industry body recommends flexibility while economic pressures continue

HCA report highlights opportunity during financial uncertainty

Melanoma smartphone app claims ‘highly variable’

Applications that assess skin cancer risk often misclassify lesions

- PMLiVE

NICE backs BMS-Pfizer’s Eliquis in atrial fibrillation

Final draft guidance recommends the drug for common heart condition

- PMLiVE

J&J sales rise but miss analysts’ targets in Q4

Leads in number of FDA approvals since 2009

- PMLiVE

Takeda launches new business in China

Will serve as hub for importing medicines from across the world

Novartis day

Novartis gets EU approval for Bexsero meningitis B shot

Offers protection for all ages above two months

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links